Seven Eight Capital’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-151,171
| Closed | -$2.8M | – | 669 |
|
|
2024
Q1 | $2.8M | Buy |
151,171
+84,964
| +128% | +$1.57M | 0.29% | 96 |
|
|
2023
Q4 | $2.07M | Buy |
66,207
+8,908
| +16% | +$279K | 0.24% | 117 |
|
|
2023
Q3 | $1.19M | Buy |
57,299
+3,575
| +7% | +$74.5K | 0.14% | 201 |
|
|
2023
Q2 | $1.29M | Buy |
+53,724
| New | +$1.29M | 0.21% | 154 |
|
|
2022
Q4 | – | Sell |
-26,935
| Closed | -$441K | – | 388 |
|
|
2022
Q3 | $441K | Buy |
+26,935
| New | +$441K | 0.09% | 306 |
|
|
2022
Q2 | – | Sell |
-10,923
| Closed | -$265K | – | 372 |
|
|
2022
Q1 | $265K | Buy |
+10,923
| New | +$265K | 0.04% | 435 |
|
|
2020
Q4 | – | Sell |
-5,258
| Closed | -$217K | – | 387 |
|
|
2020
Q3 | $217K | Sell |
5,258
-4,710
| -47% | -$194K | 0.05% | 508 |
|
|
2020
Q2 | $483K | Buy |
+9,968
| New | +$483K | 0.35% | 94 |
|
|
2020
Q1 | – | Sell |
-93,099
| Closed | -$3.98M | – | 439 |
|
|
2019
Q4 | $3.98M | Sell |
93,099
-44,370
| -32% | -$1.9M | 0.21% | 146 |
|
|
2019
Q3 | $4.95M | Buy |
137,469
+109,225
| +387% | +$3.93M | 0.26% | 111 |
|
|
2019
Q2 | $755K | Buy |
28,244
+20,300
| +256% | +$543K | 0.04% | 438 |
|
|
2019
Q1 | $213K | Buy |
+7,944
| New | +$213K | 0.01% | 523 |
|
|
2017
Q4 | – | Sell |
-35,403
| Closed | -$1.33M | – | 438 |
|
|
2017
Q3 | $1.33M | Buy |
+35,403
| New | +$1.33M | 0.16% | 202 |
|
|
2017
Q2 | – | Sell |
-294
| Closed | -$10K | – | 544 |
|
|
2017
Q1 | $10K | Sell |
294
-10,800
| -97% | -$367K | ﹤0.01% | 478 |
|
|
2016
Q4 | $320K | Buy |
+11,094
| New | +$320K | 0.06% | 346 |
|
|
2016
Q1 | – | Sell |
-14,400
| Closed | -$513K | – | 523 |
|
|
2015
Q4 | $513K | Buy |
14,400
+10,400
| +260% | +$371K | 0.35% | 95 |
|
|
2015
Q3 | $132K | Buy |
+4,000
| New | +$132K | 0.11% | 243 |
|
|
2015
Q1 | – | Sell |
-11,000
| Closed | -$349K | – | 481 |
|
|
2014
Q4 | $349K | Buy |
11,000
+7,400
| +206% | +$235K | 0.58% | 47 |
|
|
2014
Q3 | $89.1K | Buy |
+3,600
| New | +$89.1K | 0.07% | 345 |
|